Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Lexicon Pharmaceuticals, Inc.    LXRX   US5288721047

 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
12/16/2014 12/17/2014 12/18/2014 12/19/2014 12/22/2014 Date
0.8581(c) 0.8588(c) 0.8976(c) 0.8579(c) 0.8813 Last
3 696 872 3 310 680 6 258 476 5 123 311 505 394 Volume
+0.69% +0.08% +4.52% -4.42% +2.73% Change
More quotes
Company
Lexicon Pharmaceuticals, Inc. engages in discovery and development of breakthrough treatments for human disease.The company primarily focuses on the discovery of the functions and pharmaceutical utility of genes and the use of those gene function discoveries in the discovery and development of... 
More about the company
Surperformance© ratings of Lexicon Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Chart LEXICON PHARMACEUTICALS, I
Duration : Period :
Lexicon Pharmaceuticals, I Technical Analysis Chart | LXRX | US5288721047 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 13,5 M
EBIT 2014 -103 M
Net income 2014 -107 M
Debt 2014 -
Yield 2014 -
Sales 2015 13,6 M
EBIT 2015 -107 M
Net income 2015 -122 M
Debt 2015 75,0 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 45,5x
EV / Sales 2015 50,7x
Capitalization 612 M
More Financials
Latest news on LEXICON PHARMACEUTICALS, I
5d ago LEXICON PHARMACEUTICALS : To Present At The Oppenheimer 25th Annual Healthcare C..
12/08 LEXICON PHARMACEUTICALS : To Present At The Oppenheimer 25th Annual Healthcare C..
12/04 LEXICON PHARMACEUTICALS : Announces Proposed Common Stock Offering
12/03 LEXICON PHARMACEUTICALS : Announces Pricing Of Convertible Senior Notes Offering
11/28 LEXICON PHARMACEUTICALS : DE : Entry into a Material Definitive Agreement, Creat..
11/26 LEXICON PHARMACEUTICALS : Announces Completion Of $280 Million In Financing Tran..
11/24 LEXICON PHARMACEUTICALS : Announces Pricing of Common Stock Offering
11/24 LEXICON PHARMACEUTICALS : Announces Pricing of Convertible Senior Notes Offering
More news
Sector news
2h ago PHARMACYCLICS : Announces Update on IMBRUVICA® (ibrutinib) Waldenstrom's macrogl..
1d ago MEDIVATION : takes up $335m Curetech licensing option
3d ago ISIS PHARMACEUTICALS : IWM, HEZU: Big ETF Inflows
More sector news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF